Blue Crest Capital Management LTD Bio Rad Laboratories, Inc. Transaction History

Blue Crest Capital Management LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$286.93 - $312.59 $1.86 Million - $2.02 Million	-6,465 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$224.3 - $317.41 $1.45 Million - $2.05 Million	6,465 New	6,465 $1.98 Million
Q4 2018 Feb 14, 2019	SELL	$220.1 - $309.0 $579,523 - $813,597	-2,633 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$289.28 - $326.15 $158,525 - $178,730	-548 Reduced 17.23%	2,633 $824,000
Q2 2018 Aug 14, 2018	SELL	$244.1 - $303.88 $17.5 Million - $21.7 Million	-71,526 Reduced 95.74%	3,181 $918,000
Q1 2018 May 15, 2018	SELL	$233.97 - $274.11 $8.94 Million - $10.5 Million	-38,205 Reduced 33.84%	74,707 $18.7 Million
Q4 2017 Feb 14, 2018	BUY	$216.94 - $271.3 $8.75 Million - $10.9 Million	40,347 Added 55.6%	112,912 $26.9 Million
Q3 2017 Nov 14, 2017	BUY	$212.27 - $242.28 $15.4 Million - $17.6 Million	72,565	72,565 $16.1 Million

480

18.9M

19.8K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $7.55B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.